
Opinion|Videos|October 21, 2024
Final Thoughts on Dravet Syndrome Management
Author(s)M. Scott Perry, MD
Key Takeaways
- Early diagnosis in Dravet syndrome is critical to prevent developmental delays and cognitive impairments, enhancing long-term outcomes.
- Achieving seizure freedom is a primary goal, utilizing antiepileptic drugs, dietary therapies, and novel treatments like cannabidiol and fenfluramine.
Scott Perry, MD, discusses how effective management of Dravet syndrome requires a multidisciplinary approach, emphasizing the critical importance of early diagnosis and aggressive treatment aimed at achieving seizure freedom, which can significantly improve long-term outcomes and quality of life for patients.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- Can you provide any takeaway messages on the management of Dravet syndrome for your fellow HCPs?
- Please also touch on the importance of early diagnosis and seizure freedom.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
uniQure Submits BLA for Gene Therapy in HD, AAN, AHS Issue Updated Guideline on Migraine Prevention, CTE Prevalence, Brain Donation Findings in Former NFL Players
2
Phase 4 Study Highlights Valbenazine's Positive Impact on Patient-Reported Quality of Life, Daily Functioning in Tardive Dyskinesia
3
FDA Action Update, August 2026: Approvals, Clearances, and Designations
4
FDA Approves Zilganersen, First Treatment for Alexander Disease
5















